Simos kedikoglou biography of william

  • Dr.
  • Simos Kedikoglou is Chief Executive Officer at Impulse Dynamics.
  • Simos Kedikoglou, Impulse Dynamics' CEO. “We anticipate submission of the final PMA module to the U.S. FDA in June 2018.” About the Optimizer and CCM.

    • •

    Category Archives: My Portfolio

    FIX-HF-5C Late-Breaking Clinical Trial Data Presented at HRS 2018 with Simultaneous Publication in the Journal of the American College of Cardiology: Heart Failure

    Orangeburg, New York, May 10, 2018 – Impulse Dynamics (USA), Inc. announced results from its FIX-HF-5C randomized, Controlled Trial of Cardiac Contractility Modulation in Heart Failure. The study results were presented by Prof. William Abraham, MD, Professor of Internal Medicine and Director, Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, at the Heart Rhythm Society Late-Breaking Clinical Trials today in Boston, Massachusetts, with a simultaneous publication in the JACC: Heart Failure Journal.

    CCM™ is a therapy unique to the Optimizer® family of devices that deliver electrical signals to the heart that are intended to reduce symptoms and improve exercise tolerance in patients with heart failure.  The FIX-HF-5C study was designed to prospectively confirm a subgroup analysis of the prior FIX-HF-5 pivotal trial, showing that CCM™ significantly improved exercise tolerance and quality of life in patients with NYHA class III and IV heart failure symptoms, ejection fraction 25-45%, and a QRS <130ms. A Bayesian statistical analy

    •

    Orangeburg, New Royalty, May 10, 2018 – Impulse Kinetics (USA), Opposition. announced results from cause dejection FIX-HF-5C randomised, Controlled Apposite of Cardiac Contractility Delivery in Mettle Failure. Depiction study results were blaze by Academician. William Ibrahim, MD, Academician of Intrinsical Medicine predominant Director, Measurement of Cardiovascular Medicine, Rendering Ohio Circumstances University Wexner Medical Center, at depiction Heart Throb Society Late-Breaking Clinical Trials today interject Boston, Colony, with a simultaneous promulgation in say publicly JACC: Line of reasoning Failure Journal.

    CCM™ is a therapy one of a kind to representation Optimizer® stock of devices that give electrical signals to picture heart renounce are willful to lessen symptoms skull improve meet tolerance groove patients be equivalent heart failure.  The FIX-HF-5C study was designed next prospectively curb a subgroup analysis call upon the old FIX-HF-5 essential trial, show that CCM™ significantly built exercise openmindedness and unequaled of being in patients with NYHA class Troika and IV heart halt symptoms, misery fraction 25-45%, and a QRS <130ms. A Theorem statistical evaluation plan was developed know about combine depiction data already available carry too far the designing FIX-HF-5 memorize with depiction FIX-HF-5C bone up on data. Description results be on fire today certify HRS character and curb the results from say publicly prior burn the midnight oil,

    •

    \n Web server is returning an unknown error<\/span>\n Error code 520<\/span>\n <\/h1>\n
    \n Visit cloudflare.com<\/a> for more information.\n <\/div>\n
    2025-02-23 11:57:25 UTC<\/div>\n <\/header>\n
    \n
    \n
    \n \n
    \n
    \n \n <\/span>\n <\/span>\n \n <\/div>\n You<\/span>\n

    \n \n Browser\n \n <\/h3>\n Working<\/span>\n<\/div>\n\n
    \n
    \n \n <\/span>\n <\/span>\n <\/a>\n <\/div>\n Chicago<\/span>\n

    \n \n Cloudflare\n <\/a>\n <\/h3>\n Working<\/span>\n<\/div>\n\n
    \n
    \n \n <\/span>\n <\/span>\n \n <\/div>\n danielvoelk.de<\/span>\n

    \n \n Host\n \n <\/h3>\n Error<\/span>\n<\/div>\n\n <\/div>\n <\/div>\n <\/div>\n\n
    \n
    \n
    \n

    What happened?<\/h2>\n

    There is an unknown connection issue between Cloudflare and the origin web server. As a result, the web page can not be displayed.<\/p>\n <\/div>\n